Fingerprint
Dive into the research topics of 'A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
Matthew Mahoney, Vishnu C. Damalanka, Michael A. Tartell, Dong hee Chung, Andre Luiz Lourenço, Dustin Pwee, Anne E. Mayer Bridwell, Markus Hoffmann, Jorine Voss, Partha Karmakar, Nurit P. Azouz, Andrea M. Klingler, Paul W. Rothlauf, Cassandra E. Thompson, Melody Lee, Lidija Klampfer, Christina L. Stallings, Marc E. Rothenberg, Stefan Pohlmann, Sean P.J. Whelan
- Department of Biochemistry & Molecular Biophysics
- Department of Molecular Microbiology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Washington University School of Medicine
- COVID-19 Researchers
- Siteman Cancer Center
- DBBS - Plant and Microbial Biosciences
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Biochemistry, Biophysics, and Structural Biology
- DBBS - Molecular Cell Biology
- DBBS - Cancer Biology
- Center for Women's Infectious Disease Research (cWIDR)
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations